Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma

Inclusion Criteria

• •Patients with biopsy proven newly diagnosed rhabdomyosarcoma.
• •Patients less than or equal to 30 years of age.
• •Patients must be treated with a standardly accepted chemotherapy regimen.
• •May not have metastatic disease unless aged 2-10 with embryonal histology.
• •Must be willing to receive follow-up care for a minimum of five years after treatment at MGH and annual visits unless it is too difficult to return to MGH for follow-up care. In that event, they must be willing to have their outside medical information released to us to track the results.
• •Timing of radiation must be according to the IRB protocol upon which the patient is treated within either 35 days of last chemotherapy or surgery.